The Motley Fool

2 FTSE 100 dividend stocks that could help you quit your job

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Couple relaxing on a beach in front of a sunset
Image source: Getty Images.

The rate at which NMC Health (LSE: NMC) is lifting dividends suggests that investors may make an absolute packet in the years ahead.

The FTSE 100 business — which provides private healthcare to citizens in 13 countries across the Middle East — has witnessed eye-popping earnings growth in recent years. And in line with its vow to pursue a dividend payout ratio of  20-30% of post-tax profits, this has made it happy hunting for income chasers.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

Dividends at NMC have doubled during the past three years alone, culminating in 2017’s full-year payout of 13p per share. With earnings predicted to stomp 38% and 24% higher in 2018 and 2019, respectively, the healthcare giant is expected to lift the dividend to 18.1p and 23.9p per share for these respective years.

Great growth at bargain prices

Now subsequent yields of 0.5% for this year and 0.7% for the next period may not overwhelm you. However, the promise of strong and sustained profits expansion long into the future still makes the Footsie share a compelling income bet, in my opinion.

As I noted last time out, NMC is embarked on an ambitious M&A programme to turbocharge profits growth in its fast-growing emerging nations. And last month it carved out a joint venture with the General Organization for Social Insurance, the biggest pension fund in Saudi Arabia, to create one of the largest private healthcare operator in the country with bases across multiple cities, including the capital Riyadh.

NMC saw group revenues leap 31% in 2017 as patient numbers continued to surge (up 34% year-on-year to 5.8m, to be precise). However, a forward PEG reading of 0.9 doesn’t reflect the likelihood that turnover will keep tearing higher. The business is a steal right now.

A dependable diamond

Unilever (LSE: ULVR) is another share I’m expecting to provide the sort of reliable, impressive earnings growth that could make you a fortune.

As I noted last time out, the formidable pricing power of the household goods manufacturer cannot be underestimated, with the popularity of its goods remaining broadly undimmed regardless of any pressure on consumer spending power. Labels such as Domestos bleach and Magnum ice cream are proven cash cows that can be relied on to generate profit rises whatever the weather.

What’s more, Unilever’s layers of diversification also gives earnings that little bit extra visibility. Whether talking about about its sizeable geographic presence that sees it straddle both the developed and developing world, or the vast range of product types that it offers (from deodorants to washing powder and shower gels to tea bags), the business has the strength in depth to protect itself from weakness in one or two places or product segments.

Accordingly, City analysts are expecting earnings at the FTSE 100 firm to keep rising, and they are predicting advances of 1% and 10% in 2018 and 2019, respectively. And this feeds into expectations that dividends should keep growing quickly too — rewards of 131.8p per share for this year and 142.8p for next year are currently estimated, resulting in bulky yields of 3.1% and 3.4%.

It may carry an elevated forward P/E ratio of 20.9 times, but I reckon Unilever is worth every penny.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.